SEC Form 4 · accession 0001209191-16-091783
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randall S Livingston
Director
Period of report
Jan 13, 2016
Accepted (ET)
Jan 15, 2016 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 13, 2016 | M | 1,250 | $10.73 | A | 7,399 | D | |
| Common StockF1,F2 | Jan 13, 2016 | S | 1,250 | $32.14 | D | 6,149 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy | $10.73 | Jan 13, 2016 | M | 1,250 | D | May 25, 2007 | May 25, 2016 | Common Stock | 1,250 | 0 | D |
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 11, 2015.
- F2Represents actual sale price.